Aisling M. McEvoy

Aisling M. McEvoy

Auto-generated profile, based on publicly available information

Aisling M. McEvoy

Monash University

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2025 in Journal of the American Geriatrics Society
Verified
Journal Article
Open access
AMAisling M. McEvoy
Aisling M. McEvoy
ALAili V. Langford
Aili V. Langford
SLShin J. Liau
Shin J. Liau
DGDarshna Goordeen
Darshna Goordeen
EREmily Reeve
Emily Reeve
JTJustin Turner
Justin Turner
Background: Benzodiazepine receptor agonists (BZRAs) (benzodiazepines and z‐drugs) may provide limited benefits in the management of insomnia when used short‐term. However, they increase the risk of harms including falls, fractures, hospitalizations, and cognitive impairment. Deprescribing (cessation) of BZRAs may be beneficial for older adults and people living with cognitive impairment as they are at heightened risk of adverse events. This review investigated the effects of patient‐directed, non‐pharmacological interventions to support deprescribing of BZRAs used for insomnia in older adults and people living with cognitive impairment.Methods: Embase, CENTRAL, Scopus, and Medline were searched in January 2024 with no publication date restrictions. Screening, data extraction, and risk of bias assessments (ROB2 for randomized studies, ROBINS‐I for non‐randomized studies) were conducted independently by two authors. Outcomes of interest included the proportion of participants who ceased BZRAs, reduction in BZRAs, switching to another medication, sleep outcomes, and clinical outcomes. Studies were included if they investigated BZRA deprescribing in older adults (≥ 65 years) or people living with cognitive impairment.Results: Seventeen reports analyzing 16 studies in hospital, community, and aged care settings were included. BZRA cessation rates ranged between 23% to 72% for written education (n = 6); 14% to 57% for combined written and verbal education (n = 5); and 9% to 100% for multi‐component interventions (n = 6). One report investigated a BZRA deprescribing educational intervention in people with cognitive impairment and found comparable effectiveness to participants without cognitive impairment. Most studies were at a high risk of bias.Conclusions: Patient‐directed interventions led to BZRA cessation, although there was significant variability between studies. It is unknown if all interventions examined are similarly effective for people living with cognitive impairment. Further research investigating approaches to deprescribing BZRAs in older adults or people with cognitive impairment is required.

13 April 2024 in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
Verified
Journal Article
Open access
JTJustin Turner
Justin Turner
KNKelda Newport
Kelda Newport
AMAisling M. McEvoy
Aisling M. McEvoy
TSTara Smith
Tara Smith
CTCara Tannenbaum
Cara Tannenbaum
DKDebbie V. Kelly
Debbie V. Kelly
Background: Sustainable implementation of new professional services into clinical practice can be difficult. In 2019, a population-wide initiative called SaferMedsNL was implemented across the province of Newfoundland and Labrador (NL), to promote appropriate medication use. Two evidence-based interventions were adapted to the context of NL to promote deprescribing of proton pump inhibitors and sedatives. The objective of this study was to identify and prioritize which actions supported the implementation of deprescribing in community practice for pharmacists, physicians and nurse practitioners across the province. Methods: Community pharmacists, physicians and nurse practitioners were invited to participate in virtual focus groups. Nominal Group Technique was used to elicit responses to the question: “What actions support the implementation of deprescribing into the daily workflow of your practice?” Participants prioritized actions within each group while thematic analysis permitted comparison across groups. Results: Five focus groups were held in fall 2020 involving pharmacists ( n = 11), physicians ( n = 7) and nurse practitioners ( n = 4). Participants worked in rural ( n = 10) and urban ( n = 12) settings. The different groups agreed on what the top 5 actions were, with the top 5 receiving 68% of the scores: (1) providing patient education, (2) allocating time and resources, (3) building interprofessional collaboration and communication, (4) fostering patient relationships and (5) aligning with public awareness strategies. Conclusion: Pharmacists, physicians and nurse practitioners identified similar actions that supported implementing evidence-based deprescribing into routine clinical practice. Sharing these strategies may help others embed deprescribing into daily practice and assist the uptake of medication appropriateness initiatives by front-line providers. Can Pharm J (Ott) 2024;157:xx-xx.

27 July 2025 in Journal of Alzheimer’s Disease
Verified
Journal Article
Open access
EREmily Reeve
Emily Reeve
KCKatherine Cowan
Katherine Cowan
LELisa Kalisch Ellett
Lisa Kalisch Ellett
RSRon G Sinclair
Ron G Sinclair
APAnn Pietsch
Ann Pietsch
NANagham Ailabouni
Nagham Ailabouni
Background: People living with Alzheimer's disease and other types of dementia are vulnerable to medicine-related problems. More research is needed to support achieving quality use of medicines in people living with dementia. Objective: To determine the top 10 unanswered quality use of medicines questions for people living with dementia, as prioritized by Australians living with dementia, their carers, and healthcare professionals. Methods: The James Lind Alliance Priority Setting Partnership method was used. This manuscript reports the second half of the priority setting process. Using a quantitative survey, consumers (people living with dementia, their carers and family and friends) and healthcare professionals selected up to ten research questions about quality use of medicines that they felt were most important. The research questions were informed by a previous national qualitative survey and evidence checking process to identify those that were unanswered. An online workshop was then conducted with consumers and healthcare professionals to prioritize the unanswered questions, resulting in a top 10 list. Results: 171 consumers and 67 healthcare professionals completed the survey and the workshop included 17 participants. The top 10 priorities related to shared decision making, education of healthcare professionals, communication between healthcare professionals, reducing the use of unnecessary and harmful medicines, managing medicines safely at home, medicine reviews, residential aged care facilities and managing pain, behavioral changes, depression and anxiety. Conclusions: Targeting research efforts towards these identified consumer and healthcare professional priorities will ensure research funds are being directed to the most urgent areas of need in practice.

5 November 2025 in Innovations in Education and Teaching International
Verified
Journal Article
Closed access
ALAngelina Lim
Angelina Lim
AMAisling M McEvoy
Aisling M McEvoy
ZCZachary Cobucci
Zachary Cobucci
PTPerri Teoh
Perri Teoh
MCMia Curigliano
Mia Curigliano
LBLiza Barbour
Liza Barbour

30 September 2025 in International Journal of Innovation in Science and Mathematics Education
Verified
Journal Article
Closed access
SHStefan G. Huth
Stefan G. Huth
SMSusan J. Van de Meene
Susan J. Van de Meene
AMAisling M. McEvoy
Aisling M. McEvoy
RHRichard A. Hughes
Richard A. Hughes
LMLauren T. May
Lauren T. May
Environmental and social sustainability is an increasingly significant factor for the pharmaceutical industry. Higher education programs need to equip future pharmaceutical professionals with the knowledge, skills and attitudes to effectively address sustainability problems and seize emerging opportunities. Sustainability competency (SC) frameworks may offer guidance for developing sustainability curricula, but there is little precedence for their integration into programs that do not specialise in sustainability or the environment. This study explores the application of SC frameworks for designing learning and assessment activities, and gauges student attitudes towards sustainability in a module of the Monash University Master of Pharmaceutical Science degree. A mixed methods approach involving a student attitude survey and a reflective assessment task was undertaken (11% response rate). Students discussed insights and experiences that mapped onto each of the systems thinking, problem-solving, strategic thinking, collaboration/interpersonal futures-thinking, and values thinking competencies. Of note, most students considered sustainability as being relevant for their future pharmaceutical science careers. The SC framework provided insight into student learning and gaps, as well as pedagogical design.

6 May 2024 in Canadian Pharmacists Journal / Revue des Pharmaciens du Canada
Verified
Journal Article
Open access
KNKelda Newport
Kelda Newport
ALAili V. Langford
Aili V. Langford
AMAisling M. McEvoy
Aisling M. McEvoy
DKDebbie V. Kelly
Debbie V. Kelly
TSTara Smith
Tara Smith
JTJustin Turner
Justin Turner